Regulators from the US, Europe, and UK to Japan, Australia, Singapore, and Hong Kong have been working on rule revisions to harmonize data requirements for OTC derivatives reporting – changes that present a significant burden to financial institutions.
Regulation Asia co-founder Nick Wakefield sat down with Brock Arnason, Founder and Chief Executive Officer at Droit, to discuss the alignment between different reporting regimes, the challenges for firms needing to accommodate the new requirements, and best practice recommendations for reporting architecture.